These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles. Zhang Y; Li Z; Zhang K; Yang G; Wang Z; Zhao J; Hu R; Feng N Int J Pharm; 2016 Sep; 511(1):57-64. PubMed ID: 27374194 [TBL] [Abstract][Full Text] [Related]
3. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Song A; Zhang X; Li Y; Mao X; Han F Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734 [TBL] [Abstract][Full Text] [Related]
4. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation. Dudhipala N; Janga KY; Gorre T Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077 [TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin. Zhang Q; Yang H; Sahito B; Li X; Peng L; Gao X; Ji H; Wang L; Jiang S; Guo D Colloids Surf B Biointerfaces; 2020 Mar; 187():110649. PubMed ID: 31767412 [TBL] [Abstract][Full Text] [Related]
7. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related]
8. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles. Das S; Ng WK; Tan RB Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790 [TBL] [Abstract][Full Text] [Related]
9. New Peptide Functionalized Nanostructured Lipid Carriers with CNS Drugs and Evaluation Anti-proliferative Activity. Silva S; Marto J; Gonçalves LM; Duarte D; Soares OSGP; Vasques-Nóvoa F; Almeida AJ; Vale N Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806112 [TBL] [Abstract][Full Text] [Related]
10. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol. Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044 [TBL] [Abstract][Full Text] [Related]
11. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691 [TBL] [Abstract][Full Text] [Related]
12. Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations. Mura P; Maestrelli F; D'Ambrosio M; Luceri C; Cirri M Pharmaceutics; 2021 Mar; 13(4):. PubMed ID: 33804945 [TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy? Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462 [TBL] [Abstract][Full Text] [Related]
14. Nanostructured lipid carriers incorporating prickly pear seed oil for the encapsulation of vitamin A. AlZahabi S; Sakr OS; Ramadan AA J Cosmet Dermatol; 2019 Dec; 18(6):1875-1884. PubMed ID: 30784168 [TBL] [Abstract][Full Text] [Related]
15. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir. Seyfoddin A; Al-Kassas R Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312 [TBL] [Abstract][Full Text] [Related]
16. Optimized Nanoparticles for Enhanced Oral Bioavailability of a Poorly Soluble Drug: Solid Lipid Nanoparticles Versus Nanostructured Lipid Carriers. Darwish MKM; El-Enin ASMA; Mohammed KHA Pharm Nanotechnol; 2022; 10(1):69-87. PubMed ID: 35142275 [TBL] [Abstract][Full Text] [Related]
17. Nanoscale Delivery of Resveratrol towards Enhancement of Supplements and Nutraceuticals. Neves AR; Martins S; Segundo MA; Reis S Nutrients; 2016 Mar; 8(3):131. PubMed ID: 26950147 [TBL] [Abstract][Full Text] [Related]
18. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides. Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758 [TBL] [Abstract][Full Text] [Related]
19. Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats. Zhang C; Peng F; Liu W; Wan J; Wan C; Xu H; Lam CW; Yang X Int J Nanomedicine; 2014; 9():1049-63. PubMed ID: 24591827 [TBL] [Abstract][Full Text] [Related]
20. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations. Das S; Ng WK; Tan RB Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]